Page last updated: 2024-09-04

pomalidomide and Abnormal Karyotype

pomalidomide has been researched along with Abnormal Karyotype in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alegre, A; Campana, F; Delimpasi, S; Facon, T; Harrison, SJ; Hulin, C; Inchauspé, M; Macé, S; Perrot, A; Richardson, P; Risse, ML; Simpson, D; Spencer, A; Sunami, K; van de Velde, H; Vlummens, P; Wang, MC; Yong, K	1

Other Studies

1 other study(ies) available for pomalidomide and Abnormal Karyotype

Article	Year
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics. British journal of haematology, 2021, Volume: 194, Issue:1 Topics: Abnormal Karyotype; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Chromosomes, Human, Pair 1; Clinical Trials, Phase III as Topic; Dexamethasone; Febrile Neutropenia; Female; Humans; Immunologic Factors; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pneumonia; Randomized Controlled Trials as Topic; Recurrence; Risk; Salvage Therapy; Thalidomide; Trisomy	2021

Article

Year

Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics.

British journal of haematology, 2021, Volume: 194, Issue:1

Topics: Abnormal Karyotype; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Chromosomes, Human, Pair 1; Clinical Trials, Phase III as Topic; Dexamethasone; Febrile Neutropenia; Female; Humans; Immunologic Factors; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pneumonia; Randomized Controlled Trials as Topic; Recurrence; Risk; Salvage Therapy; Thalidomide; Trisomy

2021